MedPath

RENITAB

RENITAB

Discontinued
DIN Number

02068427

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

cardinaux-medicinat inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02068427
AIG Number0412692001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:01.00*
Health Canada Classification

ACTIVE INGREDIENTS (4)

BUCHUActive
Strength: 64.8 MG
Monograph: BUCHU
COLLINSONIA CANADENSISActive
Strength: 32.4 MG
Monograph: COLLINSONIA CANADENSIS
POTASSIUM NITRATEActive
Strength: 97.2 MG
Monograph: POTASSIUM NITRATE
UVA URSIActive
Strength: 48.6 MG
Monograph: UVA URSI

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.